HealthTree Logo HealthTree Foundation
Donate
HealthTree Logo
Donate
Personal Health Record
  • My Feed
  • Recently viewed

Learn

  • Topics
  • Events

Explore

  • Find treatments & trials
  • Participate in research
  • Find a coach
  • Find a specialist
  • Talk to a patient navigator
  • Get involved
  • For researchers
  • For healthcare providers
  • About us
  • Get involved
  • For researchers
  • For healthcare providers
  • About us

Create your Personal Health Record and unlock support built around you

Aligned with your diagnosis, treatment and where you are in your care. It lets HealthTree show you:

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Learn more about HealthTree
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Video

BETA - What GPRC5D therapy is FDA approved in myeloma?

Posted by
HealthTree Logo HealthTree
• May 5, 2026

Description

What GPRC5D therapy is FDA approved in myeloma?

On this video

Healthtree contact Mark Schroeder, MD

Mark Schroeder, MD

Multiple Myeloma Specialist

Related Content

  • Event Pursuing Deeper Responses With Linvoseltamab in Newly Diagnosed Multiple Myeloma Patients
  • Video Lower Infections with Elranatamab in Multiple Myeloma in Real-World Settings | EHA 2026
  • News All About Elranatamab (ELREXFIO)
  • Video LINKER-MM1: Linvoseltamab Shows Promise Across High-Risk Myeloma | EHA 2026
  • Video Promising Results with Elranatamab + Iberdomide from MagnetisMM-30| Attaya Suvannasankha, MD
  • Event Elranatamab: How it works, how it's being used, and how it compares to other bispecifics.